Abstract B98: AUY922, a novel HSP90 inhibitor: Final results of a phase I dose escalation study in Japanese patients with advanced solid malignancies.

2011 ◽  
Author(s):  
Yusuke Onozawa ◽  
Toshihiko Doi ◽  
Kentaro Yamazaki ◽  
Junichiro Watanabe ◽  
Nozomu Fuse ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Escalation ◽  
Japanese Patients ◽  
Hsp90 Inhibitor ◽  
Dose Escalation Study ◽  
Solid Malignancies

scholarly journals Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors

2014 ◽  
Vol 74 (3) ◽  
pp. 629-636 ◽  
Author(s):  
Toshihiko Doi ◽  
Yusuke Onozawa ◽  
Nozomu Fuse ◽  
Takayuki Yoshino ◽  
Kentaro Yamazaki ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Japanese Patients ◽  
Hsp90 Inhibitor ◽  
Advanced Solid Tumors ◽  
Dose Escalation Study

Phase I dose escalation study of high dose carfilzomib monotherapy for Japanese patients with relapsed or refractory multiple myeloma

2016 ◽  
Vol 104 (5) ◽  
pp. 596-604 ◽  
Author(s):  
Shinsuke Iida ◽  
Kensei Tobinai ◽  
Masafumi Taniwaki ◽  
Yoshihisa Shumiya ◽  
Toru Nakamura ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Phase I ◽  
Dose Escalation ◽  
Japanese Patients ◽  
High Dose ◽  
Dose Escalation Study ◽  
Refractory Multiple Myeloma

9155 Sunitinib combined with pemetrexed and cisplatin in patients with advanced solid malignancies: phase I dose escalation study

2009 ◽  
Vol 7 (2) ◽  
pp. 552
Author(s):  
N. Blais ◽  
D.R. Camidge ◽  
D.J. Jonker ◽  
D. Soulières ◽  
R.C. Doebele ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Escalation ◽  
Dose Escalation Study ◽  
Solid Malignancies

scholarly journals A Phase I Dose-Escalation Study of ZD6474 in Japanese Patients with Solid, Malignant Tumors

2006 ◽  
Vol 1 (9) ◽  
pp. 1002-1009 ◽  
Author(s):  
Tomohide Tamura ◽  
Hironobu Minami ◽  
Yasuhide Yamada ◽  
Noboru Yamamoto ◽  
Tatsu Shimoyama ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Escalation ◽  
Malignant Tumors ◽  
Japanese Patients ◽  
Dose Escalation Study ◽  
Solid Malignant Tumors

A phase I dose-escalation study of the Hsp90 inhibitor STA-9090 administered twice weekly in patients with solid tumors.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 3083-3083 ◽  
Author(s):  
J. M. Cleary ◽  
E. I. Heath ◽  
E. L. Kwak ◽  
B. J. Dezube ◽  
L. Gandhi ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Hsp90 Inhibitor ◽  
Dose Escalation Study

A phase I dose-escalation study of the Hsp90 inhibitor STA-9090 administered once weekly in patients with solid tumors.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 2529-2529 ◽  
Author(s):  
J. W. Goldman ◽  
R. N. Raju ◽  
G. A. Gordon ◽  
V. M. Vukovic ◽  
R. Bradley ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Hsp90 Inhibitor ◽  
Dose Escalation Study

A phase I dose-escalation study of zd0473 combined with paclitaxel in refractory solid malignancies

2001 ◽  
Vol 37 ◽  
pp. S74-S75 ◽  
Author(s):  
U. Gatzemeier ◽  
C. Twelves ◽  
D.A. Anthoney ◽  
G. Pentheroudakis ◽  
G. Groth ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Escalation ◽  
Dose Escalation Study ◽  
Solid Malignancies
Sign in / Sign up

Export Citation Format

Share Document